Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 6 | 2018 | 511 | 1.94 | Why? |
| Immune Evasion | 9 | 2021 | 2081 | 1.55 | Why? |
| Evolution, Molecular | 5 | 2018 | 3691 | 1.32 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 3 | 2018 | 386 | 1.24 | Why? |
| Mutation | 16 | 2021 | 12376 | 1.13 | Why? |
| Influenza A Virus, H3N2 Subtype | 2 | 2018 | 572 | 1.01 | Why? |
| Antibodies, Neutralizing | 15 | 2021 | 25288 | 0.94 | Why? |
| High-Throughput Nucleotide Sequencing | 8 | 2021 | 3633 | 0.93 | Why? |
| HIV Antibodies | 2 | 2018 | 776 | 0.89 | Why? |
| Influenza A Virus, H1N1 Subtype | 5 | 2019 | 2984 | 0.84 | Why? |
| Orthomyxoviridae | 3 | 2018 | 1168 | 0.84 | Why? |
| Spike Glycoprotein, Coronavirus | 12 | 2021 | 37182 | 0.76 | Why? |
| Antibodies, Viral | 15 | 2021 | 51949 | 0.75 | Why? |
| HIV-1 | 3 | 2019 | 3365 | 0.75 | Why? |
| HIV Fusion Inhibitors | 1 | 2019 | 80 | 0.74 | Why? |
| Myxovirus Resistance Proteins | 2 | 2018 | 77 | 0.72 | Why? |
| Single-Cell Analysis | 2 | 2019 | 2450 | 0.71 | Why? |
| Genetic Variation | 4 | 2019 | 3919 | 0.66 | Why? |
| Mutant Proteins | 1 | 2018 | 328 | 0.65 | Why? |
| Neutralization Tests | 7 | 2021 | 6698 | 0.63 | Why? |
| Epitope Mapping | 2 | 2018 | 1240 | 0.62 | Why? |
| Nucleoproteins | 2 | 2018 | 223 | 0.62 | Why? |
| Genetic Fitness | 1 | 2018 | 339 | 0.61 | Why? |
| Drug Resistance, Viral | 3 | 2019 | 1083 | 0.60 | Why? |
| Models, Genetic | 1 | 2017 | 434 | 0.55 | Why? |
| AIDS Vaccines | 1 | 2018 | 452 | 0.52 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.51 | Why? |
| Protein Domains | 6 | 2021 | 6563 | 0.50 | Why? |
| Selection, Genetic | 1 | 2017 | 691 | 0.49 | Why? |
| Sequence Analysis, RNA | 2 | 2019 | 2290 | 0.49 | Why? |
| Coronavirus 229E, Human | 1 | 2021 | 1241 | 0.48 | Why? |
| Antibodies, Monoclonal | 7 | 2021 | 8041 | 0.47 | Why? |
| Influenza, Human | 5 | 2020 | 10779 | 0.44 | Why? |
| HIV | 1 | 2018 | 1116 | 0.43 | Why? |
| Binding Sites | 5 | 2021 | 6201 | 0.43 | Why? |
| Anti-Retroviral Agents | 1 | 2019 | 1099 | 0.42 | Why? |
| Saccharomyces cerevisiae | 2 | 2020 | 339 | 0.37 | Why? |
| Madin Darby Canine Kidney Cells | 3 | 2018 | 640 | 0.34 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.34 | Why? |
| HEK293 Cells | 6 | 2021 | 8394 | 0.33 | Why? |
| Epitopes | 4 | 2021 | 4113 | 0.33 | Why? |
| DNA Mutational Analysis | 3 | 2018 | 581 | 0.32 | Why? |
| Influenza A virus | 1 | 2018 | 2234 | 0.30 | Why? |
| Molecular Docking Simulation | 1 | 2020 | 6902 | 0.28 | Why? |
| Influenza Vaccines | 1 | 2020 | 2941 | 0.27 | Why? |
| Immunity, Innate | 2 | 2019 | 6570 | 0.27 | Why? |
| Host-Pathogen Interactions | 3 | 2018 | 11041 | 0.26 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.25 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.25 | Why? |
| A549 Cells | 2 | 2019 | 2066 | 0.24 | Why? |
| Amino Acid Substitution | 2 | 2021 | 1706 | 0.24 | Why? |
| Dogs | 3 | 2018 | 2529 | 0.24 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.23 | Why? |
| Biohazard Release | 1 | 2021 | 54 | 0.22 | Why? |
| Viral Nonstructural Proteins | 1 | 2019 | 4810 | 0.22 | Why? |
| Gene Library | 1 | 2020 | 234 | 0.20 | Why? |
| Chlamydia trachomatis | 1 | 2020 | 172 | 0.19 | Why? |
| Amino Acid Sequence | 4 | 2018 | 6049 | 0.19 | Why? |
| Protein Folding | 1 | 2020 | 270 | 0.19 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.19 | Why? |
| Proteostasis | 1 | 2018 | 90 | 0.19 | Why? |
| Lentivirus | 1 | 2020 | 310 | 0.18 | Why? |
| HIV Envelope Protein gp41 | 1 | 2019 | 153 | 0.18 | Why? |
| Animals | 11 | 2021 | 78931 | 0.18 | Why? |
| Humans | 33 | 2021 | 930598 | 0.17 | Why? |
| Molecular Chaperones | 1 | 2018 | 124 | 0.17 | Why? |
| Saccharomyces cerevisiae Proteins | 1 | 2017 | 66 | 0.17 | Why? |
| Protein Conformation, beta-Strand | 1 | 2018 | 414 | 0.16 | Why? |
| Viral Core Proteins | 1 | 2017 | 134 | 0.16 | Why? |
| Antigens, Viral | 3 | 2018 | 6298 | 0.16 | Why? |
| Mutagenesis | 1 | 2018 | 394 | 0.16 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2018 | 530 | 0.15 | Why? |
| Fertility | 1 | 2020 | 367 | 0.15 | Why? |
| Mice | 4 | 2021 | 21357 | 0.15 | Why? |
| Endoplasmic Reticulum | 1 | 2018 | 430 | 0.15 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.15 | Why? |
| Cell Line | 3 | 2021 | 12040 | 0.15 | Why? |
| HLA Antigens | 1 | 2021 | 830 | 0.15 | Why? |
| Phylogeny | 5 | 2021 | 13341 | 0.15 | Why? |
| Mutation Rate | 1 | 2018 | 382 | 0.15 | Why? |
| Viral Fusion Proteins | 1 | 2019 | 399 | 0.14 | Why? |
| HIV Infections | 2 | 2019 | 11620 | 0.14 | Why? |
| HIV Envelope Protein gp120 | 1 | 2017 | 267 | 0.14 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.14 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.14 | Why? |
| Thermodynamics | 1 | 2018 | 873 | 0.13 | Why? |
| Containment of Biohazards | 1 | 2020 | 762 | 0.13 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.13 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.13 | Why? |
| Organ Specificity | 1 | 2018 | 1070 | 0.13 | Why? |
| Antibody Specificity | 1 | 2018 | 1328 | 0.13 | Why? |
| RNA, Viral | 2 | 2018 | 32276 | 0.13 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.12 | Why? |
| Amino Acids | 1 | 2017 | 552 | 0.12 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.12 | Why? |
| Virion | 1 | 2020 | 1444 | 0.12 | Why? |
| Phenotype | 2 | 2020 | 4037 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.11 | Why? |
| Temperature | 2 | 2018 | 2305 | 0.11 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.11 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.11 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.11 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.11 | Why? |
| Genotype | 2 | 2021 | 4697 | 0.11 | Why? |
| Gene Expression | 2 | 2018 | 3332 | 0.11 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2018 | 2134 | 0.10 | Why? |
| Crystallography, X-Ray | 1 | 2018 | 2689 | 0.10 | Why? |
| beta-Lactamases | 1 | 2017 | 759 | 0.10 | Why? |
| Seasons | 2 | 2021 | 4071 | 0.10 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.10 | Why? |
| Kinetics | 1 | 2018 | 3238 | 0.10 | Why? |
| Gene Expression Profiling | 2 | 2018 | 3788 | 0.10 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.10 | Why? |
| Polysaccharides | 1 | 2017 | 854 | 0.10 | Why? |
| Immune System | 1 | 2018 | 1479 | 0.09 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.09 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.09 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.09 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.07 | Why? |
| China | 2 | 2021 | 50654 | 0.07 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Female | 8 | 2021 | 380317 | 0.06 | Why? |
| Linoleic Acids | 1 | 2021 | 51 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Male | 6 | 2021 | 367725 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.05 | Why? |
| Fisheries | 1 | 2020 | 57 | 0.05 | Why? |
| Aged | 4 | 2021 | 215776 | 0.05 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.05 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.05 | Why? |
| Zygote | 1 | 2018 | 10 | 0.05 | Why? |
| Biophysical Phenomena | 1 | 2018 | 78 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| Models, Biological | 2 | 2018 | 4907 | 0.05 | Why? |
| Adult | 4 | 2021 | 244371 | 0.05 | Why? |
| SUMO-1 Protein | 1 | 2017 | 13 | 0.05 | Why? |
| Secretory Pathway | 1 | 2018 | 39 | 0.05 | Why? |
| Calmodulin | 1 | 2017 | 15 | 0.05 | Why? |
| Hemagglutination Inhibition Tests | 1 | 2018 | 191 | 0.05 | Why? |
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 27 | 0.05 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.04 | Why? |
| Chick Embryo | 1 | 2018 | 249 | 0.04 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.04 | Why? |
| Unfolded Protein Response | 1 | 2018 | 134 | 0.04 | Why? |
| Antigenic Variation | 1 | 2018 | 249 | 0.04 | Why? |
| Infant | 1 | 2020 | 30274 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.04 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2018 | 253 | 0.04 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.04 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.04 | Why? |
| Disease | 1 | 2017 | 126 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Protein Structure, Secondary | 1 | 2018 | 1077 | 0.03 | Why? |
| Immune Sera | 1 | 2018 | 884 | 0.03 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2021 | 1267 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Ships | 1 | 2020 | 1046 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Mathematical Concepts | 1 | 2011 | 370 | 0.02 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Stochastic Processes | 1 | 2011 | 369 | 0.02 | Why? |
| Nanoparticles | 1 | 2021 | 2040 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.02 | Why? |
| Oseltamivir | 1 | 2011 | 583 | 0.02 | Why? |
| Antiviral Agents | 2 | 2018 | 41703 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Travel | 1 | 2021 | 7220 | 0.01 | Why? |
| Machine Learning | 1 | 2017 | 4395 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |